Medicinal Products

CellCept

Name CellCept
Active Substance mycophenolate mofetil
Prescription na recept
Type of prescription ograničeni recept (tvrda kapsula, prašak za koncentrat za otopinu za infuziju, prašak za oralnu suspenziju, tableta)
Distribution u ljekarni
ATC Code L04AA06
Medicinal product marketed in the Croatia Da
Educational materials
for healthcare professionals
Upitnik za zdravstvene radnike, verzija 1
Obrazac za prijavu i praćenje trudnoće za zdravstvene radnike, verzija 1
Vodič za zdravstvene radnike, verzija 2
Educational materials
for patients / caregivers
Vodič za bolesnike, verzija 2

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/cellcept

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o izmijenjenim preporukama za kontracepciju povezanim s primjenom mofetilmikofenolata/mikofenolatne kiseline (CellCept, Myfortic, Trixin) 22.01.2018 Roche d.o.o., Novartis Hrvatska d.o.o., Pliva Hrvatska d.o.o.
Back